ISA Pharmaceuticals B.V. is an immunotherapy company developing rationally designed, fully synthetic immunotherapeutics against cancer and persistent viral infections. The Company has built a proprietary immunotherapy platform based on the Synthetic Long Peptide (SLP®) concept and AMPLIVANT®technology. SLP®immunotherapies are designed to fully harness and direct the body’s own defenses towards fighting the disease. In December 2017, ISA Pharmaceuticals closed a clinical immuno-oncology collaboration with Regeneron to advance its SLP®lead compound ISA101, an immunotherapy targeting human papillomavirus type 16 (HPV16)-induced cancer, in combination with cemiplimab (REGN2810, Libtayo®), a PD-1 (programmed cell death protein 1) antibody in development by Regeneron, which was recently approved by the FDA as monotherapy for patients with advanced cutaneous squamous cell carcinoma. ISA develops a diverse SLP®immunotherapy portfolio targeting unmet medical needs in cancer and chronic infections, including tailored therapy for rare diseases.
ISA´s most advanced clinical-stage immunotherapeutic is ISA101, an SLP® immunotherapy targeting human papillomavirus (HPV)-induced diseases. It is currently in clinical development in advanced and recurrent cervical cancer, incurable HPV16-postive solid tumors and anal intraepithelial neoplasia (AIN). Clinical proof-of-concept has been established in vulvar intraepithelial neoplasia (VIN), a pre-cancerous disease caused by HPV.
The company was founded in 2004 by Aglaia Oncology Fund and is based in Leiden, The Netherlands. For more information, please visit www.isa-pharma.com
SLP® and AMPLIVANT® are registered trademarks in Europe.
Company Details
- Employees
- 5
- Founded
- 2004
- Address
- J.h. Oortweg 19-21, Leiden,2333 Ch,netherlands
- Phone
- (713) 322-310
- in****@****rma.com
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- isa-pharma.com
- Keywords
- Immunotherapy, Persistant Viral Infections, Oncology, Cancer, Synthetic Long Peptides, T cell activation.
- HQ
- Leiden
Isa Pharmaceuticals Questions
Isa Pharmaceuticals's helpline number is (713) 322-310
Isa Pharmaceuticals's website is isa-pharma.com
Isa Pharmaceuticals's LinkedIn profile is https://nl.linkedin.com/company/isa-pharmaceuticals
Isa Pharmaceuticals has
5 employees.
View email and phone details for 5
employees at Isa Pharmaceuticals.
Isa Pharmaceuticals's industry is
Biotechnology Research
Isa Pharmaceuticals's top competitors are
Leyden Labs,
Orca Therapeutics,
Lumicks,
Scenic Biotech,
Lava Therapeutics N.v.,
Agendia,
Uniqure,
Cimcure B.v.,
Proqr Therapeutics,
Avantium.
Isa Pharmaceuticals's support email address is info@isa-pharma.com
Isa Pharmaceuticals's categories are Biotechnology Research
Isa Pharmaceuticals's founding year is 2004
